Obesity and T2D are also associated with hyperinsulinemia and increases in circulating cytokines, branched chain amino acids (BCAAs), and other metabolites, which can, directly and indirectly, affect liver metabolism by altering insulin signaling and substrate delivery to the liver (20–22). The gene discussed is INS; the disease is hyperinsulinism.